Department of Radiology
Found 33 results
Filters: Author is Jeitner, Thomas M  [Clear All Filters]
2005
Jeitner TM, E Delikatny J, Ahlqvist J, Capper H, Cooper AJL.  2005.  Mechanism for the inhibition of transglutaminase 2 by cystamine.. Biochem Pharmacol. 69(6):961-70.
Pinto JT, Van Raamsdonk JM, Leavitt BR, Hayden MR, Jeitner TM, Thaler HT, Krasnikov BF, Cooper AJL.  2005.  Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.. J Neurochem. 94(4):1087-101.
2003
Cooper AJL, Krasnikov BF, Okuno E, Jeitner TM.  2003.  L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes? Biochem J. 376(Pt 1):169-78.
2002
Cooper AJL, Jeitner TM, Gentile V, Blass JP.  2002.  Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? Neurochem Int. 40(1):53-67.
Gibson GE, Zhang H, Xu H, Park LCH, Jeitner TM.  2002.  Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme.. Biochim Biophys Acta. 1586(2):177-89.
Cooper AJL, Jeitner TM, Blass JP.  2002.  The role of transglutaminases in neurodegenerative diseases: overview.. Neurochem Int. 40(1):1-5.
Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJL, Ratan RR, M Beal F et al..  2002.  Therapeutic effects of cystamine in a murine model of Huntington's disease.. J Neurosci. 22(20):8942-50.
Kim SYoul, Jeitner TM, Steinert PM.  2002.  Transglutaminases in disease.. Neurochem Int. 40(1):85-103.